The Detrimental Role of Regulatory T Cells in Nonalcoholic Steatohepatitis

Nonalcoholic steatohepatitis (NASH) is induced by steatosis and metabolic inflammation. While involvement of the innate immune response has been shown, the role of the adaptive immune response in NASH remains controversial. Likewise, the role of regulatory T cells (Treg) in NASH remains unclear although initial clinical trials aim to target these regulatory responses. High‐fat high‐carbohydrate (HF‐HC) diet feeding of NASH‐resistant BALB/c mice as well as the corresponding recombination activating 1 (Rag)‐deficient strain was used to induce NASH and to study the role of the adaptive immune response. HF‐HC diet feeding induced strong activation of intrahepatic T cells in BALB/c mice, suggesting an antigen‐driven effect. In contrast, the effects of the absence of the adaptive immune response was notable. NASH in BALB/c Rag1−/− mice was substantially worsened and accompanied by a sharp increase of M1‐like macrophage numbers. Furthermore, we found an increase in intrahepatic Treg numbers in NASH, but either adoptive Treg transfer or anti‐cluster of differentiation (CD)3 therapy unexpectedly increased steatosis and the alanine aminotransferase level without otherwise affecting NASH. Conclusion: Although intrahepatic T cells were activated and marginally clonally expanded in NASH, these effects were counterbalanced by increased Treg numbers. The ablation of adaptive immunity in murine NASH led to marked aggravation of NASH, suggesting that Tregs are not regulators of metabolic inflammation but rather enhance it.

[1]  M. Manns,et al.  Splenectomy Prior to Experimental Induction of Autoimmune Hepatitis Promotes More Severe Hepatic Inflammation, Production of IL-17 and Apoptosis , 2021, Biomedicines.

[2]  M. Manns,et al.  Treg-specific IL-2 therapy can reestablish intrahepatic immune regulation in autoimmune hepatitis. , 2020, Journal of autoimmunity.

[3]  T. Rassaf,et al.  9-PAHSA Prevents Mitochondrial Dysfunction and Increases the Viability of Steatotic Hepatocytes , 2020, International journal of molecular sciences.

[4]  M. Manns,et al.  Absence of Atg7 in the liver disturbed hepatic regeneration after liver injury , 2020, Liver international : official journal of the International Association for the Study of the Liver.

[5]  M. Manns,et al.  Autoimmune hepatitis induction can occur in the liver , 2019, Liver international : official journal of the International Association for the Study of the Liver.

[6]  E. Albano,et al.  Adaptive immunity: an emerging player in the progression of NAFLD , 2019, Nature Reviews Gastroenterology & Hepatology.

[7]  Caroline L. Wilson,et al.  Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer , 2019, Nature Medicine.

[8]  Z. Goodman,et al.  Liver Transplantation (LT) for Cryptogenic Cirrhosis (CC) and Nonalcoholic Steatohepatitis (NASH) Cirrhosis , 2018, Medicine.

[9]  T. Chavakis,et al.  Innate immune cells in the adipose tissue , 2018, Reviews in Endocrine and Metabolic Disorders.

[10]  K. Moore,et al.  Inflammatory Ly6Chi monocytes and their conversion to M2 macrophages drive atherosclerosis regression , 2017, The Journal of clinical investigation.

[11]  L. Henry,et al.  Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes , 2016, Hepatology.

[12]  Ya Cao,et al.  Tumor-Associated Neutrophils Recruit Macrophages and T-Regulatory Cells to Promote Progression of Hepatocellular Carcinoma and Resistance to Sorafenib. , 2016, Gastroenterology.

[13]  F. Tacke,et al.  Hepatic macrophages in homeostasis and liver diseases: from pathogenesis to novel therapeutic strategies , 2016, Cellular and Molecular Immunology.

[14]  Ji Luo,et al.  NAFLD causes selective CD4+ T lymphocyte loss and promotes hepatocarcinogenesis , 2016, Nature.

[15]  H. Hermanns,et al.  Progression from Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis Is Marked by a Higher Frequency of Th17 Cells in the Liver and an Increased Th17/Resting Regulatory T Cell Ratio in Peripheral Blood and in the Liver , 2016, The Journal of Immunology.

[16]  S. Friedman,et al.  Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis. , 2015, Gastroenterology.

[17]  Mark S. Anderson,et al.  Autoimmune hepatitis in a murine autoimmune polyendocrine syndrome type 1 model is directed against multiple autoantigens , 2015, Hepatology.

[18]  Xingchun Wang,et al.  Serum transforming growth factor beta 3 predicts future development of nonalcoholic fatty liver disease. , 2015, International journal of clinical and experimental medicine.

[19]  Aijaz Ahmed,et al.  Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States. , 2015, Gastroenterology.

[20]  M. Manns,et al.  Intrahepatic regulatory T cells in autoimmune hepatitis are associated with treatment response and depleted with current therapies. , 2014, Journal of hepatology.

[21]  H. Moch,et al.  Metabolic activation of intrahepatic CD8+ T cells and NKT cells causes nonalcoholic steatohepatitis and liver cancer via cross-talk with hepatocytes. , 2014, Cancer cell.

[22]  M. Yeh,et al.  Strain dependence of diet‐induced NASH and liver fibrosis in obese mice is linked to diabetes and inflammatory phenotype , 2014, Liver international : official journal of the International Association for the Study of the Liver.

[23]  J. Stenvang,et al.  Homogenous 96-Plex PEA Immunoassay Exhibiting High Sensitivity, Specificity, and Excellent Scalability , 2014, PloS one.

[24]  K. Irvine,et al.  The portal inflammatory infiltrate and ductular reaction in human nonalcoholic fatty liver disease , 2014, Hepatology.

[25]  Rohit Kohli,et al.  IL-17 Signaling Accelerates the Progression of Nonalcoholic Fatty Liver Disease in Mice , 2014, Hepatology.

[26]  G. Targher,et al.  Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis , 2013, Nature Reviews Gastroenterology &Hepatology.

[27]  M. Manns,et al.  Genetic predisposition and environmental danger signals initiate chronic autoimmune hepatitis driven by CD4+ T cells , 2013, Hepatology.

[28]  M. Manns,et al.  Enrichment of Regulatory T Cells in Acutely Rejected Human Liver Allografts , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[29]  Virginia Nguyen,et al.  Kuppfer Cells Trigger Nonalcoholic Steatohepatitis Development in Diet-induced Mouse Model through Tumor Necrosis Factor-α Production* , 2012, The Journal of Biological Chemistry.

[30]  A. Quaas,et al.  FOXP3+ regulatory T cells in autoimmune hepatitis are fully functional and not reduced in frequency. , 2012, Journal of hepatology.

[31]  E. Assier,et al.  Interleukin-23: A key cytokine in inflammatory diseases , 2011, Annals of medicine.

[32]  L. Chatenoud Immune therapy for type 1 diabetes mellitus—what is unique about anti-CD3 antibodies? , 2010, Nature Reviews Endocrinology.

[33]  E. Jackvony,et al.  Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis , 2010, Hepatology.

[34]  Christophe Benoist,et al.  Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters , 2009, Nature Medicine.

[35]  J. Zieleński,et al.  Normalization of Obesity-Associated Insulin Resistance through Immunotherapy: CD4+ T Cells Control Glucose Homeostasis , 2009, Nature Medicine.

[36]  R. Green,et al.  Mechanisms of hepatic steatosis in mice fed a lipogenic methionine choline-deficient diet , 2008 .

[37]  K. Lindor,et al.  Nonalcoholic fatty liver disease. , 2007, Annals of epidemiology.

[38]  R. Ravi,et al.  A high‐fat diet and regulatory T cells influence susceptibility to endotoxin‐induced liver injury , 2007, Hepatology.

[39]  O. Cummings,et al.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease , 2005, Hepatology.

[40]  L. Henry,et al.  NAFLD AND NASH: Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention , 2018 .

[41]  R. Green,et al.  The methionine-choline deficient dietary model of steatohepatitis does not exhibit insulin resistance. , 2004, Journal of hepatology.